Dominique Bonneau

Professor of Medical Genetics

Université d'Angers
Country flagFrance
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Variants in RNU4-2 , encoding the small nuclear RNA (snRNA) U4, were recently identified as a major cause of neurodevelopmental disorders (ReNU syndrome). Here, we investigated de novo variants in 50 snRNAs in a French cohort of 23,649 individuals with rare disorders and collected data of additional patients through an international collaboration. Altogether, we identified 133 probands with pathogenic or likely pathogenic variants in RNU4-2 and 15 individuals with de novo and/or recurrent variants in constrained regions of RNU5B-1 , one of five genes encoding U5. These variants cluster in evolutionarily conserved regions of U4 and U5 essential for splicing. RNU4-2 variants affecting stem III are associated with milder phenotypes than those in the T-loop (quasi-pseudoknot). Phaseable variants associated with severe phenotypes occurred on the maternal allele. Individuals with RNU4-2 variants show specific defects in alternative 5’ splice site usage, correlating with variant location and clinical severity. Additionally, we report an episignature associated with severe ReNU syndrome. This study further highlights the importance of de novo variants in snRNAs and establishes RNU5B-1 as a new neurodevelopmental disorder gene.

Year:

2024

Neurodevelopmental proteasomopathies represent a distinctive category of neurodevelopmental disorders (NDD) characterized by genetic variations within the 26S proteasome, a protein complex governing eukaryotic cellular protein homeostasis. In our comprehensive study, we identified 23 unique variants in PSMC5 , which encodes the AAA-ATPase proteasome subunit PSMC5/Rpt6, causing syndromic NDD in 38 unrelated individuals. Overexpression of PSMC5 variants altered human hippocampal neuron morphology, while PSMC5 knockdown led to impaired reversal learning in flies and loss of excitatory synapses in rat hippocampal neurons. PSMC5 loss-of-function resulted in abnormal protein aggregation, profoundly impacting innate immune signaling, mitophagy rates, and lipid metabolism in affected individuals. Importantly, targeting key components of the integrated stress response, such as PKR and GCN2 kinases, ameliorated immune dysregulations in cells from affected individuals. These findings significantly advance our understanding of the molecular mechanisms underlying neurodevelopmental proteasomopathies, provide links to research in neurodegenerative diseases, and open up potential therapeutic avenues.

Year:

2024

Collaborators (39)

Caroline Schluth-Bolard

University of Lyon

FRANCE
View details

Ype Elgersma

Full professor

Erasmus MC

NETHERLANDS
View details

Tamar Harel

-

ISRAEL
View details

Geeske van Woerden

Associate professor

Erasmus University Rotterdam

NETHERLANDS
View details

Julien Van-Gils

Aix-Marseille University

FRANCE
View details

Rebecca Ganetzky

Associate Professor

Children's Hospital of Philadelphia

UNITED STATES
View details

EFTERPI PAVLIDOU

Assistant Professor of Pediatrics

University of Ioannina

GREECE
View details

Peter Krawitz

University of Bonn

GERMANY
View details

Julie Steffann

-

FRANCE
View details

Arnaud Droit

Professor

Université Laval Faculté de médecine

CANADA
View details

Elsa Leitão

Universitätsklinikum Essen Institut für Humangenetik

GERMANY
View details

Tzung-Chien Hsieh

University Hospital Bonn

GERMANY
View details

Evan Eichler

Howard Hughes Medical Institute

UNITED STATES
View details

Florence Petit

Université de Lille

FRANCE
View details

Pierre Blanc

Head of the laboratory

Assistance Publique - Hôpitaux de Paris

FRANCE
View details

Marie-Pierre Bousquet

Institute of Pharmacology and Structural Biology

FRANCE
View details

Mathilde Renaud

Faculty member / Enseignant-chercheur / Enseignante-chercheuse

Université de Lorraine

FRANCE
View details

Peter Werner Hildebrand

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY
View details

Stéphane Bézieau

Université de Nantes

FRANCE
View details

Andrew Dauber

The George Washington University School of Medicine and Health SCiences

UNITED STATES
View details

Frederic Laumonnier

Team Leader, Research Director

INSERM

FRANCE
View details

Dmitriy Niyazov

Associate Professor

Duke University

UNITED STATES
View details

Renske Oegema

UMC Utrecht

NETHERLANDS
View details

Rami Abou Jamra

University Hospital Leipzig

GERMANY
View details

Gael Nicolas

PUPH

University of Rouen

FRANCE
View details

Jens Meiler

Vanderbilt University

UNITED STATES
View details

Kimberly McDonald

Assistant Professor

University of Mississippi Medical Center

UNITED STATES
View details

Elke Hammer

University Medicine Greifswald

GERMANY
View details

Elke Krueger

Director

University Medicine Greifswald

GERMANY
View details

Annick Toutain

-

FRANCE
View details

Tychele Turner

Assistant Professor

Washington University School of Medicine

UNITED STATES
View details

Benoit Arveiler

Prof - Group leader

Bordeaux University Hospital

FRANCE
View details

Frédéric Ebstein

Group Leader

Université de Nantes

FRANCE
View details

Andreas Grabrucker

Lecturer (Assist. Prof)

University of Limerick

IRELAND
View details

Gregory Costain

Hospital for Sick Children

CANADA
View details

Antonio Vitobello

Full professor

Université de Bourgogne

FRANCE
View details

Anita Rauch

University of Zurich

SWITZERLAND
View details

Julien Marcoux

CNRS Research Director

Institute of Pharmacology and Structural Biology

FRANCE
View details

Miroslava Hancarova

Charles University

CZECH REPUBLIC
View details